Kanker kolon Dokter Terbaik di Israel - TOP-24 dokter

Dr. Pelles Sharon menempuh pelatihan di Royal Marsden – pusat kanker terkemuka di Eropa – dengan spesialisasi pada kanker gastrointestinal. Beliau mengepalai Institut Tumor Sistem Pencernaan di Ichilov.

• Menjadi ahli dalam HIPEC dan terapi target kanker kolorektal
• Mengajar di Fakultas Kedokteran Universitas Tel Aviv
• Menjadi peneliti yang memublikasikan studi tentang pengobatan adenokarsinoma pankreas
• Menjadi anggota Asosiasi Onkologi dan Radiologi Israel

Prof. Ofer Merimsky memimpin Unit Onkologi Jaringan Lunak dan Tulang di Sourasky Medical Center – salah satu rumah sakit kanker terkemuka di Israel.

• Spesialisasi selama 30+ tahun dalam kasus sarkoma dan tumor kompleks
• Menjalani pelatihan fellowship di Institut Gustave Roussy, pusat kanker terkemuka di Eropa
• Anggota fakultas ESMO untuk protokol pengobatan sarkoma
• Menerbitkan penelitian luas tentang terapi kanker inovatif

Prof. Nadir Arber memimpin salah satu dari sedikit Pusat Pencegahan Kanker khusus di Israel, yang berfokus secara eksklusif pada penghentian kanker sebelum dimulai.

• Pengalaman lebih dari 30 tahun dalam menangani tumor saluran pencernaan
• Penulis lebih dari 300 karya ilmiah tentang pencegahan kanker dan terapi gen
• Kepala Pusat Pencegahan Kanker Terpadu di Tel Aviv Sourasky Medical Center
• Menjadi anggota asosiasi onkologi dan gastroenterologi internasional utama
• Menyelesaikan pekerjaan penelitian di NewYork-Presbyterian Center yang bergengsi

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Profesor Ido Wolf mengepalai seluruh departemen onkologi di Tel Aviv Medical Center, salah satu rumah sakit terkemuka di Israel. Beliau memiliki pengalaman spesifik dalam menangani tumor kolorektal dan hati.

• Memimpin Divisi Onkologi Medis di Sourasky Medical Center (Ichilov)
• Memiliki pengalaman lebih dari 20 tahun di bidang onkologi dan penyakit dalam
• Pelatihan medis di Fakultas Kedokteran Sackler yang bergengsi, Universitas Tel Aviv
• Spesialisasi dalam diagnosis kompleks dan penatalaksanaan kanker gastrointestinal

Kepala Departemen Bedah Kolorektal di Sourasky Medical Center – spesialis terkemuka dengan pengalaman bedah lebih dari 20 tahun.

• Ahli dalam teknik bedah terbuka maupun invasif minimal
• Melakukan prosedur kompleks seperti operasi Whipple
• Berfokus secara eksklusif pada bedah perut dan kolorektal

Direktur rawat inap onkologi di Pusat Medis Tel Aviv, Ichilov – Dr. Stepfansky memiliki pengalaman lebih dari 20 tahun di bidang onkologi.

• Spesialisasi dalam onkologi di Pusat Medis Tel Aviv
• Peneliti utama dalam studi onkologi klinis
• Bersertifikat dewan dalam penyakit dalam dan onkologi
• Diakui untuk kasus kanker usus besar yang kompleks

Profesor Tulchinsky adalah Direktur Unit Bedah Kolon dan Rektum serta Kepala Divisi Bedah Umum di Tel Aviv Sourasky Medical Center.

• Pakar terkemuka dalam penyakit kolorektal dan anal termasuk kanker
• Melakukan bedah restoratif untuk kanker rektum dan kondisi familial
• Spesialisasi dalam reseksi usus laparoskopi invasif minimal
• Unit ini merupakan pemimpin dalam prosedur kolorektal diagnostik dan terapeutik

Dr. Auala Hubert memimpin Pusat Kanker Gastrointestinal di Hadassah Medical Center, dengan spesialisasi pada kanker usus besar.

• Memiliki 33 tahun pengalaman di bidang onkologi dan radioterapi
• Memegang sertifikasi dewan baik dalam bidang onkologi maupun radioterapi
• Menjadi dokter senior di Rumah Sakit Universitas Hadassah
• Menjadi anggota Komite Kanker Gastrointestinal di Israel
• Menempuh pendidikan kedokteran di Rumah Sakit Universitas Hadassah yang bergengsi

Seorang spesialis yang berfokus secara eksklusif pada pembedahan kanker kolon dengan lebih dari 25 tahun praktik akademis dan klinis. Beliau adalah Direktur Program Residensi Bedah di Hadassah Medical Center.

• Tersertifikasi Konsil Bedah Umum Israel sejak 1998
• Instruktur, Dosen, dan Lektor Kepala dalam bidang bedah selama puluhan tahun
• Anggota dari berbagai asosiasi bedah ternama
• Lancar berbahasa Inggris dan Ibrani untuk komunikasi pasien

Dr. Alexander Beny mengepalai Layanan Malignansi Gastrointestinal di Rambam Medical Center, membawa puluhan tahun keahlian terfokus pada kanker usus besar.

• Memegang sertifikasi dewan Eropa dan Israel dalam bidang onkologi
• Direktur Layanan Malignansi Gastrointestinal – spesialisasi dalam kanker pencernaan
• Menjalankan klinik Onkologi Gastrointestinal khusus
• Menyelesaikan pelatihan lanjutan dalam teknik radioterapi modern
• Dokter Senior di Departemen Onkologi dengan pengalaman klinis yang luas

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Wakil Kepala Departemen Onkologi – peran kepemimpinan senior yang mengawasi perawatan kanker yang kompleks di Rambam Medical Center.

• Spesialisasi dalam merawat pasien dengan kanker usus besar
• Bekerja di Rambam – rumah sakit tersier terkemuka di Israel
• Memegang posisi senior dalam memandu protokol perawatan dan penelitian

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.